Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Galdeano C

Contact information:

Galdeano Carles
Laboratori de Quemica Farmaceutica; Facultat de Farmacia; Av. Diagonal 643; 8028 Barcelona
Spain
Phone : +34934024542
Fax :
Send E-Mail to Galdeano Carles


10CHE.jpg (Full)
Reiner Elsa
The 10th International Meeting on Cholinesterases
Group
Group_10CHE.jpg (Full)
The 10th International Meeting on Cholinesterases
DSC03867.jpg (Full)
The 10th International Meeting on Cholinesterases



    Title: Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress
    Peyman M, Barroso E, Turcu AL, Estrany F, Jr., Smith D, Jurado-Aguilar J, Rada P, Morisseau C, Hammock BD and Vazquez-Carrera M <4 more author(s)>
    Ref: Biomed Pharmacother, 168:115667, 2023 : PubMed

            

    Title: Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
    Sampietro A, Perez-Areales FJ, Martinez P, Arce EM, Galdeano C, Munoz-Torrero D
    Ref: Pharmaceuticals (Basel), 15:, 2022 : PubMed

            

    Title: Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
    Grinan-Ferre C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R and Galdeano C <8 more author(s)>
    Ref: Neurotherapeutics, :, 2020 : PubMed

            

    Title: Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy
    Pallas M, Vazquez S, Sanfeliu C, Galdeano C, Grinan-Ferre C
    Ref: Biomolecules, 10:, 2020 : PubMed

            

    Title: Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
    Galdeano C, Coquelle N, Cieslikiewicz-Bouet M, Bartolini M, Perez B, Clos MV, Silman I, Jean L, Colletier JP and Munoz-Torrero D <1 more author(s)>
    Ref: Molecules, 23:, 2018 : PubMed

            

    Title: Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity
    Sola I, Castella S, Viayna E, Galdeano C, Taylor MC, Gbedema SY, Perez B, Clos MV, Jones DC and Munoz-Torrero D <3 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry, 23:5156, 2015 : PubMed

            

    Title: Shogaol-huprine hybrids: Dual antioxidant and anticholinesterase agents with beta-amyloid and tau anti-aggregating properties
    Perez-Areales FJ, Di Pietro O, Espargaro A, Vallverdu-Queralt A, Galdeano C, Ragusa IM, Viayna E, Guillou C, Clos MV and Munoz-Torrero D <4 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry, 22:5298, 2014 : PubMed

            

    Title: Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases
    Galdeano C, Viayna E, Sola I, Formosa X, Camps P, Badia A, Clos MV, Relat J, Ratia M and Munoz-Torrero D <9 more author(s)>
    Ref: Journal of Medicinal Chemistry, 55:661, 2012 : PubMed

            

    Title: Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents
    Munoz-Torrero D, Pera M, Relat J, Ratia M, Galdeano C, Viayna E, Sola I, Formosa X, Camps P and Clos MV <1 more author(s)>
    Ref: Neurodegener Dis, 10:96, 2012 : PubMed

            

    Title: Huprines as a new family of dual acting trypanocidal-antiplasmodial agents
    Defaux J, Sala M, Formosa X, Galdeano C, Taylor MC, Alobaid WA, Kelly JM, Wright CW, Camps P, Munoz-Torrero D
    Ref: Bioorganic & Medicinal Chemistry, 19:1702, 2011 : PubMed

            

    Title: Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates
    Camps P, Formosa X, Galdeano C, Gomez T, Munoz-Torrero D, Ramirez L, Viayna E, Gomez E, Isambert N and Luque FJ <9 more author(s)>
    Ref: Chemico-Biological Interactions, 187:411, 2010 : PubMed

            

    Title: Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents
    Galdeano C, Viayna E, Arroyo P, Bidon-Chanal A, Blas JR, Munoz-Torrero D, Luque FJ
    Ref: Curr Pharm Des, 16:2818, 2010 : PubMed

            

    Title: Novel huprine derivatives with inhibitory activity toward beta-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates
    Viayna E, Gomez T, Galdeano C, Ramirez L, Ratia M, Badia A, Clos MV, Verdaguer E, Junyent F and Munoz-Torrero D <10 more author(s)>
    Ref: ChemMedChem, 5:1855, 2010 : PubMed

            

    Title: Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds
    Camps P, Formosa X, Galdeano C, Munoz-Torrero D, Ramirez L, Gomez E, Isambert N, Lavilla R, Badia A and Luque FJ <8 more author(s)>
    Ref: Journal of Medicinal Chemistry, 52:5365, 2009 : PubMed

            

    Title: Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation
    Camps P, Formosa X, Galdeano C, Gomez T, Munoz-Torrero D, Scarpellini M, Viayna E, Badia A, Clos MV and Luque FJ <8 more author(s)>
    Ref: Journal of Medicinal Chemistry, 51:3588, 2008 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer